'Response assessment' diaporamas de présentation

A Perspective on Risk Analysis for the GMP Initiative

A Perspective on Risk Analysis for the GMP Initiative. H. Gregg Claycamp, Ph.D., CHP Center for Veterinary Medicine Office of New Animal Drug Evaluation hclaycam@cvm.fda.gov May 22, 2003. Outline. The Premise and Questions Basics of Risk Analysis

840 views • 49 slides

Lessons from the CLL8 study

Lessons from the CLL8 study. FCR is superior to FC in most cytogenetic subgroups with regard to: Response rates (CR, OR, MRD) Progression-free survival. FCR is safe: more neutropenias not more infections or other severe side effects

620 views • 33 slides

Regulatory Toxicology

Regulatory Toxicology. James Swenberg, D.V.M., Ph.D. Acute Toxicity Studies. Single dose - rat, mouse (5/sex/dose), dog, monkey (1/sex/dose) 14 day observation In-life observations (body wt., food consumption, clinical observations) Necropsy . Acute LD50 Values vs Toxicity.

1.24k views • 30 slides

Regulatory Toxicology

Regulatory Toxicology. James Swenberg, D.V.M., Ph.D. Acute Toxicity Studies. Single dose - rat, mouse (5/sex/dose), dog, monkey (1/sex/dose) 14 day observation In-life observations (body wt., food consumption, clinical observations) Necropsy . Acute LD50 Values vs Toxicity.

521 views • 30 slides

320 views • 18 slides

327 views • 18 slides

Presented By Christina Tsien at 2014 ASCO Annual Meeting

Presented By Christina Tsien at 2014 ASCO Annual Meeting. Current Limitations in the Response Assessment of Anti-Angiogenic Therapy. Presented By Christina Tsien at 2014 ASCO Annual Meeting. Imaging Changes Following Anti-Angiogenic Therapy.

331 views • 17 slides

Climate and Energy: Emerging Health Impacts on Pacific Islands

268 views • 14 slides